7 terminated. 7 Phase 3.
By phase and status
Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole SCY-078, Fluconazole, Echinocandin - Candidiasis, Invasive, Candidemia | Phase 3 | Terminated | 68 | 2022-08-03 | 2026-08-10 |
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis micafungin, amphotericin B deoxycholate - Candidiasis | Phase 3 | Terminated | 30 | 2013-02-01 | 2015-11-04 |
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis Anidulafungin/Fluconazole - Candidemia | Phase 3 | Terminated | 17 | 2010-12-01 | 2015-10-28 |
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients voriconazole - Candidiasis | Phase 3 | Terminated | 23 | 2010-10-01 | 2016-06-23 |
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System Active Anidulafungin, Active Caspofungin - Fungemia, Neutropenia | Phase 3 | Terminated | 21 | 2009-08-01 | 2012-12-20 |
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida Active anidulafungin, Active Caspofungin - Candidiasis, Fungemia | Phase 3 | Terminated | 41 | 2009-04-01 | 2013-08-01 |
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings Caspofungin, Placebo - Candidiasis | Phase 3 | Terminated | 1200 | 2004-10-01 | 2014-12-05 |
Narrower conditions
Candidemia (5) · Candidiasis, Invasive (3) · Mycoses (3) · Torulopsis (3) · Fungemia (2) · Neutropenia (1)
Broader conditions
Bacterial Infections and Mycoses (7) · Infections (7) · Inflammation (5) · Invasive Fungal Infections (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Sepsis (5) · Systemic Inflammatory Response Syndrome (5) · Mycoses (4) · Fungemia (3) · Candidiasis, Invasive (2) · Agranulocytosis (1) · Cytopenia (1) · Hematologic Diseases (1)
Interventions
Anidulafungin (2) · Caspofungin (2) · Fluconazole (2) · Micafungin (2) · Amphotericin B (1) · Echinocandins (1) · Injections (1) · Voriconazole (1) · amphotericin B, deoxycholate drug combination (1) · ibrexafungerp (1)
Sponsors
Pfizer (4) · Astellas Pharma Global Development, Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Scynexis, Inc. (1)
Countries
United States (4) · Bulgaria (3) · Canada (3) · China (3) · Belgium (2) · France (2) · Greece (2) · Hungary (2) · Israel (2) · Italy (2) · Philippines (2) · Poland (2) · Romania (2) · Russia (2) · Slovakia (2)
Top investigators
David Angulo, MD (1)
Results publications
PMID 28459966, PMID 28597967, PMID 33891293, PMID 27636722, PMID 29596222, PMID 31280481
NIH funding
2009 (1)